Pascale G A Van Hoydonck

Suggest Changes
Learn More
AIMS Anacetrapib is an orally active and potent inhibitor of CETP in development for the treatment of dyslipidaemia. These studies endeavoured to establish the safety, tolerability, pharmacokinetics(More)
  • 1